Company / Operating Cash Flow per Share
Idexx Laboratories Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$14.48
FY2025
5-year range
$6.42 / $14.48
FY2021-FY2025
Trend
+29.4%
vs FY2024
Sector context
#18 of 155
Health Care
What the data says
Idexx Laboratories's operating cash flow per share of $14.48 is higher than 88% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has increased for 3 consecutive years, from $6.42 in FY2022 to $14.48 in FY2025.
Based on SEC 10-K filings.
14.48 in FY2025 with a 5-year CAGR of +13.8%. Top quartile in the Health Care sector.
Improved from $10.94 to $14.48 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +31.1%
- 5-Year CAGR
- +13.8%
- 10-Year CAGR
- -
Sector benchmark
+113.8% above sector average
Key checks
Key Insights
- Idexx Laboratories's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 29.4% year-over-year.
- Ranks #18 out of 155 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.48 | +29.4% |
| FY2024 | $11.19 | +2.3% |
| FY2023 | $10.94 | +70.3% |
| FY2022 | $6.42 | -27.4% |
| FY2021 | $8.84 | +16.6% |
| FY2020 | $7.58 | +42.2% |
| FY2019 | $5.33 | +16.1% |
| FY2018 | $4.59 | +15.2% |
| FY2017 | $3.99 | +19.4% |
| FY2016 | $3.34 | +62.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026